disability

Socioeconomic status drops fast after NMOSD onset: Danish study

The risk of losing income increases dramatically within a few years after the onset of neuromyelitis optica spectrum disorder (NMOSD) in patients positive for antibodies against aquaporin-4 (AQP4), compared with the general population. That’s according to a nationwide study in Denmark that also showed AQP4-related NMOSD was strongly associated…

Tocilizumab found to be effective, safe for NMOSD: Meta-analysis

Tocilizumab, an anti-inflammatory medication used off-label for neuromyelitis optica spectrum disorder (NMOSD), can help prevent relapses (flare-ups) and ease disability while being generally safe, according to a meta-analysis. The study, “Tocilizumab treatment in neuromyelitis optica spectrum disorders: Updated meta-analysis of efficacy and safety,” was published in the journal…

My thoughts on deciding when to disclose a disability

When was the last time you Googled your name? When I do it, I find my column here at Neuromyelitis News. My work as a post-secondary teacher is rewarding, but it’s also important to demonstrate my expertise. That’s why many of my students search for my professional profile…